The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tumor Gene Test Service Market Research Report 2025

Global Tumor Gene Test Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1730370

No of Pages : 86

Synopsis
Highlights
The global Tumor Gene Test Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Tumor Gene Test Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Tumor Gene Test Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Tumor Gene Test Service in Medical Institution is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Tumor Gene Test Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Tumor Tissue, which accounted for % of the global market of Tumor Gene Test Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Gene Test Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Gene Test Service.
The Tumor Gene Test Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tumor Gene Test Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Gene Test Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. .

Some of the prominent players reviewed in the research report include:

  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • Oxford Nanopore Technologies

Product Type Insights
Global markets are presented by Tumor Gene Test Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Tumor Gene Test Service are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Tumor Gene Test Service segment by Type

  • Tumor Tissue
  • Blood

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Tumor Gene Test Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Tumor Gene Test Service market.
Tumor Gene Test Service Segment by Application

  • Medical Institution
  • Scientific Research Institutions
  • Pharmaceutical Companies
  • Individual User

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tumor Gene Test Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Tumor Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Tumor Gene Test Service industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Gene Test Service.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Gene Test Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Gene Test Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tumor Tissue
1.2.3 Blood
1.3 Market by Application
1.3.1 Global Tumor Gene Test Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Medical Institution
1.3.3 Scientific Research Institutions
1.3.4 Pharmaceutical Companies
1.3.5 Individual User
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Gene Test Service Market Perspective (2017-2028)
2.2 Tumor Gene Test Service Growth Trends by Region
2.2.1 Tumor Gene Test Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tumor Gene Test Service Historic Market Size by Region (2017-2022)
2.2.3 Tumor Gene Test Service Forecasted Market Size by Region (2023-2028)
2.3 Tumor Gene Test Service Market Dynamics
2.3.1 Tumor Gene Test Service Industry Trends
2.3.2 Tumor Gene Test Service Market Drivers
2.3.3 Tumor Gene Test Service Market Challenges
2.3.4 Tumor Gene Test Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Gene Test Service Players by Revenue
3.1.1 Global Top Tumor Gene Test Service Players by Revenue (2017-2022)
3.1.2 Global Tumor Gene Test Service Revenue Market Share by Players (2017-2022)
3.2 Global Tumor Gene Test Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Gene Test Service Revenue
3.4 Global Tumor Gene Test Service Market Concentration Ratio
3.4.1 Global Tumor Gene Test Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Gene Test Service Revenue in 2021
3.5 Tumor Gene Test Service Key Players Head office and Area Served
3.6 Key Players Tumor Gene Test Service Product Solution and Service
3.7 Date of Enter into Tumor Gene Test Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Gene Test Service Breakdown Data by Type
4.1 Global Tumor Gene Test Service Historic Market Size by Type (2017-2022)
4.2 Global Tumor Gene Test Service Forecasted Market Size by Type (2023-2028)
5 Tumor Gene Test Service Breakdown Data by Application
5.1 Global Tumor Gene Test Service Historic Market Size by Application (2017-2022)
5.2 Global Tumor Gene Test Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tumor Gene Test Service Market Size (2017-2028)
6.2 North America Tumor Gene Test Service Market Size by Country (2017-2022)
6.3 North America Tumor Gene Test Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Tumor Gene Test Service Market Size (2017-2028)
7.2 Europe Tumor Gene Test Service Market Size by Country (2017-2022)
7.3 Europe Tumor Gene Test Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Gene Test Service Market Size (2017-2028)
8.2 Asia-Pacific Tumor Gene Test Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Tumor Gene Test Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Tumor Gene Test Service Market Size (2017-2028)
9.2 Latin America Tumor Gene Test Service Market Size by Country (2017-2022)
9.3 Latin America Tumor Gene Test Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Gene Test Service Market Size (2017-2028)
10.2 Middle East & Africa Tumor Gene Test Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Tumor Gene Test Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Tumor Gene Test Service Introduction
11.1.4 Illumina Revenue in Tumor Gene Test Service Business (2017-2022)
11.1.5 Illumina Recent Development
11.2 BGI Genomics Co.,Ltd.
11.2.1 BGI Genomics Co.,Ltd. Company Detail
11.2.2 BGI Genomics Co.,Ltd. Business Overview
11.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Introduction
11.2.4 BGI Genomics Co.,Ltd. Revenue in Tumor Gene Test Service Business (2017-2022)
11.2.5 BGI Genomics Co.,Ltd. Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Tumor Gene Test Service Introduction
11.3.4 Agilent Technologies Revenue in Tumor Gene Test Service Business (2017-2022)
11.3.5 Agilent Technologies Recent Development
11.4 Macrogen
11.4.1 Macrogen Company Detail
11.4.2 Macrogen Business Overview
11.4.3 Macrogen Tumor Gene Test Service Introduction
11.4.4 Macrogen Revenue in Tumor Gene Test Service Business (2017-2022)
11.4.5 Macrogen Recent Development
11.5 Pacific Biosciences
11.5.1 Pacific Biosciences Company Detail
11.5.2 Pacific Biosciences Business Overview
11.5.3 Pacific Biosciences Tumor Gene Test Service Introduction
11.5.4 Pacific Biosciences Revenue in Tumor Gene Test Service Business (2017-2022)
11.5.5 Pacific Biosciences Recent Development
11.6 10x Genomics
11.6.1 10x Genomics Company Detail
11.6.2 10x Genomics Business Overview
11.6.3 10x Genomics Tumor Gene Test Service Introduction
11.6.4 10x Genomics Revenue in Tumor Gene Test Service Business (2017-2022)
11.6.5 10x Genomics Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Tumor Gene Test Service Introduction
11.7.4 QIAGEN Revenue in Tumor Gene Test Service Business (2017-2022)
11.7.5 QIAGEN Recent Development
11.8 GEEWIZ
11.8.1 GEEWIZ Company Detail
11.8.2 GEEWIZ Business Overview
11.8.3 GEEWIZ Tumor Gene Test Service Introduction
11.8.4 GEEWIZ Revenue in Tumor Gene Test Service Business (2017-2022)
11.8.5 GEEWIZ Recent Development
11.9 MACROGEN
11.9.1 MACROGEN Company Detail
11.9.2 MACROGEN Business Overview
11.9.3 MACROGEN Tumor Gene Test Service Introduction
11.9.4 MACROGEN Revenue in Tumor Gene Test Service Business (2017-2022)
11.9.5 MACROGEN Recent Development
11.10 Oxford Nanopore Technologies
11.10.1 Oxford Nanopore Technologies Company Detail
11.10.2 Oxford Nanopore Technologies Business Overview
11.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Introduction
11.10.4 Oxford Nanopore Technologies Revenue in Tumor Gene Test Service Business (2017-2022)
11.10.5 Oxford Nanopore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Tumor Gene Test Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tumor Tissue
Table 3. Key Players of Blood
Table 4. Global Tumor Gene Test Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Tumor Gene Test Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Tumor Gene Test Service Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Tumor Gene Test Service Market Share by Region (2017-2022)
Table 8. Global Tumor Gene Test Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Tumor Gene Test Service Market Share by Region (2023-2028)
Table 10. Tumor Gene Test Service Market Trends
Table 11. Tumor Gene Test Service Market Drivers
Table 12. Tumor Gene Test Service Market Challenges
Table 13. Tumor Gene Test Service Market Restraints
Table 14. Global Tumor Gene Test Service Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Tumor Gene Test Service Market Share by Players (2017-2022)
Table 16. Global Top Tumor Gene Test Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Gene Test Service as of 2021)
Table 17. Ranking of Global Top Tumor Gene Test Service Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Tumor Gene Test Service Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor Gene Test Service Product Solution and Service
Table 21. Date of Enter into Tumor Gene Test Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Gene Test Service Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Tumor Gene Test Service Revenue Market Share by Type (2017-2022)
Table 25. Global Tumor Gene Test Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Tumor Gene Test Service Revenue Market Share by Type (2023-2028)
Table 27. Global Tumor Gene Test Service Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Tumor Gene Test Service Revenue Market Share by Application (2017-2022)
Table 29. Global Tumor Gene Test Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Tumor Gene Test Service Revenue Market Share by Application (2023-2028)
Table 31. North America Tumor Gene Test Service Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Tumor Gene Test Service Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Tumor Gene Test Service Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Tumor Gene Test Service Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Tumor Gene Test Service Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Tumor Gene Test Service Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Tumor Gene Test Service Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Tumor Gene Test Service Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Tumor Gene Test Service Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Tumor Gene Test Service Market Size by Country (2023-2028) & (US$ Million)
Table 41. Illumina Company Detail
Table 42. Illumina Business Overview
Table 43. Illumina Tumor Gene Test Service Product
Table 44. Illumina Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 45. Illumina Recent Development
Table 46. BGI Genomics Co.,Ltd. Company Detail
Table 47. BGI Genomics Co.,Ltd. Business Overview
Table 48. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product
Table 49. BGI Genomics Co.,Ltd. Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 50. BGI Genomics Co.,Ltd. Recent Development
Table 51. Agilent Technologies Company Detail
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Tumor Gene Test Service Product
Table 54. Agilent Technologies Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 55. Agilent Technologies Recent Development
Table 56. Macrogen Company Detail
Table 57. Macrogen Business Overview
Table 58. Macrogen Tumor Gene Test Service Product
Table 59. Macrogen Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 60. Macrogen Recent Development
Table 61. Pacific Biosciences Company Detail
Table 62. Pacific Biosciences Business Overview
Table 63. Pacific Biosciences Tumor Gene Test Service Product
Table 64. Pacific Biosciences Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 65. Pacific Biosciences Recent Development
Table 66. 10x Genomics Company Detail
Table 67. 10x Genomics Business Overview
Table 68. 10x Genomics Tumor Gene Test Service Product
Table 69. 10x Genomics Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 70. 10x Genomics Recent Development
Table 71. QIAGEN Company Detail
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Tumor Gene Test Service Product
Table 74. QIAGEN Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 75. QIAGEN Recent Development
Table 76. GEEWIZ Company Detail
Table 77. GEEWIZ Business Overview
Table 78. GEEWIZ Tumor Gene Test Service Product
Table 79. GEEWIZ Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 80. GEEWIZ Recent Development
Table 81. MACROGEN Company Detail
Table 82. MACROGEN Business Overview
Table 83. MACROGEN Tumor Gene Test Service Product
Table 84. MACROGEN Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 85. MACROGEN Recent Development
Table 86. Oxford Nanopore Technologies Company Detail
Table 87. Oxford Nanopore Technologies Business Overview
Table 88. Oxford Nanopore Technologies Tumor Gene Test Service Product
Table 89. Oxford Nanopore Technologies Revenue in Tumor Gene Test Service Business (2017-2022) & (US$ Million)
Table 90. Oxford Nanopore Technologies Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Gene Test Service Market Share by Type: 2021 VS 2028
Figure 2. Tumor Tissue Features
Figure 3. Blood Features
Figure 4. Global Tumor Gene Test Service Market Share by Application in 2021 & 2028
Figure 5. Medical Institution Case Studies
Figure 6. Scientific Research Institutions Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Individual User Case Studies
Figure 9. Tumor Gene Test Service Report Years Considered
Figure 10. Global Tumor Gene Test Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Tumor Gene Test Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Tumor Gene Test Service Market Share by Region: 2021 VS 2028
Figure 13. Global Tumor Gene Test Service Market Share by Players in 2021
Figure 14. Global Top Tumor Gene Test Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Gene Test Service as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Tumor Gene Test Service Revenue in 2021
Figure 16. North America Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Tumor Gene Test Service Market Share by Country (2017-2028)
Figure 18. United States Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Tumor Gene Test Service Market Share by Country (2017-2028)
Figure 22. Germany Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Tumor Gene Test Service Market Share by Region (2017-2028)
Figure 30. China Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Tumor Gene Test Service Market Share by Country (2017-2028)
Figure 38. Mexico Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Tumor Gene Test Service Market Share by Country (2017-2028)
Figure 42. Turkey Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Tumor Gene Test Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Illumina Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 45. BGI Genomics Co.,Ltd. Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 46. Agilent Technologies Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 47. Macrogen Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 48. Pacific Biosciences Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 49. 10x Genomics Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 50. QIAGEN Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 51. GEEWIZ Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 52. MACROGEN Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 53. Oxford Nanopore Technologies Revenue Growth Rate in Tumor Gene Test Service Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’